美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultra納斯達克生物科

108.99

+0.55760.51%

盤前：107.01-1.9776-1.81%08:07 EDT

成交量：3,776

成交額：41.21萬

市值：9,154.96萬

市盈率：- -

高：110.50

開：109.74

低：107.51

收：108.43

52周最高：126.40

52周最低：55.34

股本：84.00萬

流通股本：84.00萬

量比：0.27

換手率：0.45%

股息：0.33

股息率：0.30%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

吉利德科學擴大六項免許可費自願授權協議，力推每年一次HIV預防藥Lenacapavir

Sling Therapeutics 籌集 1.23 億美元，用於推進甲狀腺相關眼病藥物的研發

百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟

百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BIB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":108.9876,"timestamp":1789588800000,"preClose":108.43,"halted":0,"volume":3776,"hourTrading":{"tag":"盘前","latestPrice":107.01,"preClose":108.9876,"latestTime":"08:07 EDT","volume":8,"amount":856.08,"timestamp":1789646849130,"change":-1.9776,"changeRate":-0.018145,"amplitude":0},"delay":0,"changeRate":0.005142488241261584,"floatShares":840000,"shares":840000,"eps":0,"marketStatus":"盤前交易","change":0.5576,"latestTime":"09-17 08:12:50 EDT","open":109.735,"high":110.5,"low":107.51,"amount":412098.464896,"amplitude":0.027575,"askPrice":113.7,"askSize":92,"bidPrice":107.02,"bidSize":140,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":108.9876,"sharesOutstanding":1040000,"nav":108.5525,"aum":91184100,"dividendRate":0.003,"bidAskSpread":0.002695,"preHourTrading":{"tag":"盘前","latestPrice":107.01,"preClose":108.9876,"latestTime":"08:07 EDT","volume":8,"amount":856.08,"timestamp":1789646849130,"change":-1.9776,"changeRate":-0.018145,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":108.37,"preClose":108.9876,"latestTime":"19:44 EDT","volume":29,"amount":3116.2656,"timestamp":1789602249698,"change":-0.6176,"changeRate":-0.005667,"amplitude":0},"volumeRatio":0.26697587620335406,"impliedVol":0.4955,"impliedVolPercentile":0.808},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.26697587620335406,"shares":840000,"dividePrice":0.327,"high":110.5,"amplitude":0.027575,"preClose":108.43,"low":107.51,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":108.9876,"committee":0.206897,"eps":0,"divideRate":0.003,"volume":3776,"delay":0,"ttmEps":0,"open":109.735,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":112.8071,"twentyDayClose":111.9849,"sixtyDayClose":88.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164691459","title":"吉利德科學擴大六項免許可費自願授權協議，力推每年一次HIV預防藥Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=1164691459","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164691459?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:31","pubTimestamp":1789561872,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，扩大其六项免许可费的自愿授权协议，覆盖其每年仅需注射一次的HIV预防药物Lenacapavir。此举旨在拓宽药物可及性，助力全球抗击艾滋病疫情。通过这一系列协议，吉利德希望加快该长效预防方案在中低收入国家的推广，以应对持续存在的公共卫生挑战。该举措不仅彰显了公司在全球健康公平方面的承诺，也为实现2030年终结艾滋病流行的目标注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","IBB","SG9999015952.SGD","LU1023059063.AUD","IE00B7SZLL34.SGD","LU0122379950.USD","LU1934455277.USD","LU2087621335.USD","BK4583","LU1037948541.HKD","LU0861579265.USD","LU0058720904.USD","LU0882574055.USD","IE00BKVL7J92.USD","SG9999015978.USD","IE00BSNM7G36.USD","LU1066051498.USD","LU1571399168.USD","TBXU","TMED","LU2089984988.USD","SG9999015986.USD","LU1430594728.SGD","LU1674673428.USD","GILD","BK4585","LU1585245621.USD","LU0965509101.SGD","LU0965509283.SGD","IE0002270589.USD","LU2468319806.SGD","LU0320765992.SGD","LU1066053197.SGD","LU2324357040.USD","LU0234570918.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU0965508806.USD","LU0859254822.USD","LU0965509010.AUD","BK4139","LU0289739699.SGD","LU2357627491.SGD","LU1037948897.HKD","BK4566","BMED","BK4588","BK4532","IE00BZ1G4Q59.USD","IBBQ","BK4578","BK4568","LU0114720955.EUR","LU1778281490.HKD","MEDI","IE00B19Z3B42.SGD","BK4550","LU0889565916.HKD","BBH","LU1057294990.SGD","LU1934455863.HKD","LU1934455194.USD","LU2112291526.USD","BIB","LU0109394709.USD","LU1674673691.USD","LU0823416689.USD","LU1839511570.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667074086","title":"Sling Therapeutics 籌集 1.23 億美元，用於推進甲狀腺相關眼病藥物的研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667074086","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667074086?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:01","pubTimestamp":1789556485,"startTime":"0","endTime":"0","summary":"Sling Therapeutics 筹集 1.23 亿美元，用于推进甲状腺相关眼病药物的研发Kunal Das/Siddhi Mahatole路透9月16日-药物研发公司Sling Therapeutics周三表示，已筹集1.23亿美元，用于推进其用于治疗甲状腺眼病的实验性口服药物的后期临床试验。该疾病会导致眼周发炎和肿胀，进而可能引发眼球突出和视力丧失。作为此次融资协议的一部分，Sling还任命了Forbion的Regina Salvat和Sectoral Asset Management的Franois Beaubien加入其董事会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4T4580NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4588","LU1061106388.HKD","BK4533","LU0122379950.USD","BK4581","LU0868494617.USD","LU2468319806.SGD","BK4566","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU1057294990.SGD","BK4139","LU1983299246.USD","LU1023059063.AUD","BIB","LU0058720904.USD","LU1571399168.USD","PBE","LU2112291526.USD","LU0889565916.HKD","BK4585","LU2089984988.USD","BK4534","IBB","TBXU","IE00BJT1NW94.SGD","VRDN","IBBQ","PJP","SG9999001440.SGD","LU2242652126.USD","LU2242646821.SGD","BK4599","IE00B2B36J28.USD","IE0009355771.USD","AMGN","IE00BFTCPJ56.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667267605","title":"百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667267605?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2322448957.HKD","LU0058720904.USD","LU0320765992.SGD","AMGN","LU0109394709.USD","LU1236620834.HKD","BMY","LU1670711123.USD","PPH","LU0868494617.USD","LU1023059063.AUD","LU2272731600.USD","BK4566","LU1983299246.USD","IHE","BK4139","BK4559","LU2125154778.USD","LU0061475181.USD","BK4585","LU0289739699.SGD","BK4533","IE00BSNM7G36.USD","LU2272731865.HKD","PBE","LU1883839398.USD","XPH","IE0009355771.USD","LU0225284248.USD","LU0225771236.USD","LU1989771016.USD","TBXU","BK4534","LU0114720955.EUR","IBB","LU1868837300.USD","FTXH","BBH","LU1236620750.USD","LU1992135399.USD","LU2473716301.USD","LU2468319806.SGD","BIB","BK4588","IE00B4R5TH58.HKD","LU1868836591.USD","LU1868836757.USD","IBBQ","LU1261432733.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629132","title":"百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629132","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629132?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:29","pubTimestamp":1789493363,"startTime":"0","endTime":"0","summary":"百时美施贵宝就奥普迪沃拟推出的生物类似药起诉安进Blake Brittain路透9月15日-百时美施贵宝公司和小野制药公司已在特拉华州联邦法院起诉安进公司，试图阻止安进公司在美国推出其畅销癌症免疫疗法药物“欧迪沃”的生物类似药。百时美施贵宝和小野制药的发言人尚未立即回应置评请求。共同开发“欧狄沃”的百时美施贵宝和小野制药指控，安进的生物类似药将侵犯该药物所涉及的七项美国专利，并请求法院在专利有效期内禁止该生物类似药的销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T4571DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU2089984988.USD","LU0096364046.USD","BK4585","LU2125154935.USD","LU0321505439.SGD","LU0122379950.USD","PJP","LU1061106388.HKD","LU1093756168.USD","LU1868837136.USD","LU0267386448.USD","LU1868836591.USD","LU1093756325.SGD","IE0002141913.USD","LU1670711123.USD","LU0306807586.USD","LU1057294990.SGD","LU1718418525.SGD","LU2125154778.USD","BK4532","BMY","BK4599","SG9999001440.SGD","LU1868836757.USD","LU2242652126.USD","LU2596442595.SGD","LU1291159041.SGD","LU2242646821.SGD","LU1323610961.USD","LU0289739699.SGD","LU1074936037.SGD","LU1989771016.USD","LU1868836914.USD","PBE","IBB","LU1670711040.USD","LU1571399168.USD","LU0114720955.EUR","LU0306806265.USD","IHE","LU0225771236.USD","LU1868837300.USD","IE00B2B36J28.USD","LU1670710661.SGD","LU2360032135.SGD","LU1261432733.SGD","LU0985481810.HKD","LU1236620750.USD","LU1023059063.AUD","LU2133065610.SGD","LU1670710588.SGD","IBBQ","LU1983299246.USD","BK4534","LU0882574055.USD","LU2112291526.USD","LU0889565916.HKD","LU0058720904.USD","LU0321505868.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4139","BK4566","LU2468319806.SGD","LU0225284248.USD","LU0456855351.SGD","BK4533","LU1585245621.USD","BK4559","LU0237698245.USD","IE00BSNM7G36.USD","LU1430594728.SGD","04332","TBXU","BK4007","AMGN","IE00BFTCPJ56.SGD","LU1032466523.USD","BBH","LU1883839398.USD","BK4588","LU0061475181.USD","BIB","LU0109394709.USD","FTXH","IE00BFXG1179.USD","IE00B4R5TH58.HKD","LU1236620834.HKD","LU0868494617.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":39,"pageCount":1,"totalSize":153,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BIB\",params:#limit:6,delay:false,,,undefined,":[]}}